1. Adam, A., Ellouz, F., Ciorbaru, R., Petit, J. F., and Lederer, E., 1975, Peptidoglycan adjuvants: minimal structure required for activity. Z. Immun.-Forsch. 149(s): 341,
2. Appleyard, G., and Maber, H. B., 1974, Plaque formation by influenza viruses in the presence of trypsin. J. Gen. Virol. 25: 351.
3. Audibert, F., Chedid, L., and Hannoun, C., 1977, Augmentation de la response immunitaire au vaccin grippal par un glycopeptide synthetique adjuvant (N-acetylmuramly-L-alanyl-D-isoglutamine), C. R. Acad. Sc. Paris, Serie D. 285: 467.
4. Azuma, I., Kishimoto, S., Yamamura, Y., and Petit, J. F., 1971, Adjuvanticity of mycobacterial cell walls. Jpn. J. Microbiol. 15: 193.
5. Azuma, I., Sugimura, K., Taniyama, T., Yamawaki, M., Yamamura, Y., Kusumoto, S., Okada, S., and Hiba, T., 1976, Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds. Infect. Immun. 14: 18.